ImmunologyPLoS ONEPeer-reviewed
CD47 blockade augments anti-GD2 driven phagocytosis in vitro but fails to improve in vivo efficacy in immune competent, chemoresistant neuroblastoma preclinical models
Courtney Himsworth, Thomas John Jackson, Chantelle E Bowers…·John Anderson
This study shows CD47 blockade enhances anti-GD2 phagocytosis in vitro but does not improve in vivo efficacy in neuroblastoma models.
DOI 10.1371/journal.pone.0353900